Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials

Probiotics are beneficial for liver cirrhosis: a systematic review and meta-analysis of randomized control trials

IntroductionGut dysbiosis may play a pivotal role in the pathogenesis of cirrhosis and the severity of complications. Numerous studies have investigated the probiotics as treatments for cirrhosis. However, there is still a lack of definitive evidence confirming the beneficial effects of probiotics o...

Full description

Bibliographic Details
Main Authors:	Xing Yang, Langhuan Lei, Wei Shi, Xiaozhen Li, Xiaozhi Huang, Liuyan Lan, Jiali Lin, Qiuyu Liang, Wei Li, Jianrong Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Medicine
Subjects:	probiotics liver cirrhosis hepatic encephalopathy liver function meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1379333/full

Similar Items

Dynamic posturography findings among patients with liver cirrhosis in Egypt
by: Wael M. Aref, et al.
Published: (2012-01-01)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
by: Razvan Igna, et al.
Published: (2022-08-01)

Frequency of H. pylori in liver cirrhosis patients with overt Hepatic encephalopathy at tertiary care hospital, Karachi.
by: Shaista Ahmed, et al.
Published: (2022-07-01)

Overview of Serum Interleukin-18 (IL-18) Levels in Liver Cirrhosis Patients and Their Correlation to Hepatic Encephalopathy
by: Anton Komala, et al.
Published: (2018-08-01)

EVALUATION OF EFFICACY OF RIFAXIMIN IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
by: Hafsa Habib, et al.
Published: (2016-12-01)

Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy
by: Igor G. Bakulin, et al.
Published: (2023-10-01)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
by: Mo-Jong Kim, et al.
Published: (2023-01-01)

Assentment of the influence of liver cirrhosis and minimal hepatic encephalopathy on quality of life
by: Diana Santos, et al.
Published: (2014-06-01)

Early mechanical ventilation for grade IV hepatic encephalopathy is associated with increased mortality among patients with cirrhosis: an exploratory study
by: Saad Saffo, et al.
Published: (2022-08-01)

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis
by: Tatsunori Hanai, et al.
Published: (2020-06-01)

Is measuring serum ammonia helpful in patients with liver cirrhosis?
by: Ioan-Cristian Lupescu, et al.
Published: (2023-03-01)

An evidence-based update on hepatic encephalopathy
by: Abdo Ayman
Published: (2006-01-01)

Hepatic Encephalopathy among Patients with Chronic Liver Disease Admitted to the Department of Internal Medicine in a Tertiary Care Centre: A Descriptive Cross-sectional Study
by: Ujjwal Karki, et al.
Published: (2023-07-01)

NUTRITIVE THERAPY OF HEPATIC ENCEPHALOPATHY AS A COMPLICATION OF LIVER CIRRHOSIS
by: Bojana Marković-Živković, et al.
Published: (2012-06-01)

Antibiotics and Liver Cirrhosis: What the Physicians Need to Know
by: Caterina Zoratti, et al.
Published: (2021-12-01)

Brief Review of the Revised Korean Association for the Study of the Liver Clinical Practice Guidelines for Liver Cirrhosis: Varices, Hepatic Encephalopathy and Related Complications
by: Eun Sun Jang
Published: (2019-11-01)

Association of Serum Ammonia Levels with Severity of Grades of Hepatic Encephalopathy in Patients Presenting to er of a Tertiary Care Hospital
by: Muhammad Dawood, et al.
Published: (2022-09-01)

Sepsis and meningoencephalitis due to Listeria monocytogenes in patients with liver cirrhosis: a case of nonhepatic encephalopathy?
by: Federico Lari, et al.
Published: (2012-10-01)

Hepatic Encephalopathy Is Not Always due to Liver Cirrhosis
by: Miriam Eva Ecker, et al.
Published: (2022-05-01)

Lacosamide as add-on treatment of focal symptomatic epilepsy in a patient with alcoholic liver cirrhosis
by: A. Romigi, et al.
Published: (2014-01-01)

Clinical Features of Refractory Ascites in Outpatients
by: Wanda Regina Caly, et al.

Current evidence on the use of probiotics in liver diseases
by: Norberto C. Chávez-Tapia, et al.
Published: (2015-08-01)

Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial
by: Mohammadreza Naderian, et al.
Published: (2017-01-01)

Morphological changes in the brain in liver cirrhosis of alcoholic and viral etiology
by: A. M. Maybogin, et al.
Published: (2022-12-01)

Efficacy and Safety of Emricasan in Liver Cirrhosis and/or Fibrosis
by: Li-ya Mu, et al.
Published: (2021-06-01)

The risk of bleeding and encephalopathy in surgical patients with liver cirrhosis
by: Petrișor Banu, et al.
Published: (2019-05-01)

Antiviral therapy of HCV-cirrhosis: case of sequential treatment and review of literature
by: Kakharman Yesmembetov, et al.
Published: (2018-03-01)

Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review
by: Essam Mohamed Elsebaie, et al.
Published: (2023-04-01)

Autoimmune hepatitis as a rare cause of cirrhosis development
by: Dominika Podgórska, et al.
Published: (2024-02-01)

Cognitive impairment after liver transplantation: residual hepatic encephalopathy or posttransplant encephalopathy?
by: Kornerup LS, et al.
Published: (2019-03-01)

Key astroglial markers in human liver cirrhosis of different degree: immunohistochemical study
by: T. V. Shulyatnikova, et al.
Published: (2022-11-01)

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy
by: Simona Parisse, et al.
Published: (2023-10-01)

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
by: Yu Jun Wong, et al.
Published: (2023-01-01)

Association between probiotic therapy and the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis
by: Ke Shi, et al.
Published: (2023-01-01)

Neurologic Safety of Etomidate-Based Sedation during Upper Endoscopy in Patients with Liver Cirrhosis Compared with Propofol: A Double-Blind, Randomized Controlled Trial
by: Jang Han Jung, et al.
Published: (2020-07-01)

New Possibilities of Hepatic Encephalopathy Correction in Patients with Liver Cirrhosis
by: I.M. Gavrysh
Published: (2014-09-01)

Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts
by: Qiao Ke, et al.
Published: (2022-09-01)

Profiles of Clinical and Liver Function Test of Hepatitis B and C Patients with Liver Cirrhosis
by: Andreas Novaldi Watang, et al.
Published: (2023-01-01)

The Relationship of Plasma Zinc Concentration and Hepatic Encephalopathy in Patients with Cirrhosis
by: Rahmatollah Rafiei, et al.
Published: (2014-11-01)

The Etiology and Pathogenesis of Hepatitis and Liver Cirrhosis under the Influence of Dysentery Toxin
by: L.A. Alimova, et al.
Published: (2015-09-01)